Skip to main content
. 2020 Mar 4;21:242. doi: 10.1186/s13063-020-4163-0

Table 3.

Study assessments

Admission Iloprost administration
d1 d2 d3 d4 d5 ICU/ IMC Ward Hospital discharge or d28 Hospital discharge or d90
Laboratory testing
 Blood count Xa Xa Xa Xa Xa Xa Xb Xc X X
 Procalcitonin Xa Xa Xa Xa Xa Xa Xb Xc X X
 IL-6 Xa Xa Xa Xa Xa Xa Xb Xc X X
 PaO2/FiO2 Xa Xa Xa Xa Xa Xa Xb Xc
 Hemoglobin Xa Xa Xa Xa Xa Xa Xb Xc X X
 Hemostasis parameters Xa Xa Xa Xa Xa Xa Xb Xc X X
 Renal parameters Xa Xa Xa Xa Xa Xa Xb Xc X X
Clinical parameters
 Ventilation support including ventilation parameters Xa Xa Xa Xa Xa Xa Xa
 Prone positioning Xa Xa Xa Xa Xa Xa Xa
 ECMO Xa Xa Xa Xa Xa Xa Xa
 Relaxation Xa Xa Xa Xa Xa Xa Xa
 High-frequency ventilation Xa Xa Xa Xa Xa Xa Xa
Tracheotomy
 Hemodynamic parameters Xa Xa Xa Xa Xa Xa Xb X X X
 Vasopressor therapy Xa Xa Xa Xa Xa Xa Xa
 Inotrope therapy Xa Xa Xa Xa Xa Xa Xa
 Fluid balance Xa Xa Xa Xa Xa Xa Xa
 Transfusion of red blood cells X X X X X X Xb X X X
 Transfusion of thrombocytes X X X X X X Xb X X X
Anticoagulation
 Infection X X X X X X Xb X X X
 Anti-infective therapy X X X X X X Xb X X X
 Length of stay in ICU
 Length of stay in hospital
 Discharge location X X
 Death
 Cause of death
Scores
 Richmond Agitation-Sedation Scale (RASS) Xa Xa Xa Xa Xa Xa Xa
 SOFA scored X X X X X X X X X
 Barthel Index X X

IMC intermediate care

aAssessment on daily basis during ICU stay

bAssessment on daily basis until day 14 and then once per week during ICU/IMC stay

cAssessment once per week on ward

dSOFA score during ventilation support once per week

eqSOFA score spontaneous breathing